Form D · Biotechnology
PharmaInvest LLC
New York, NY · CIK 0001559264
Offering snapshot reported Oct 23, 2012 · SEC filing
- Reported sold
- $7.72M Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 22, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 23, 2012 | Initial | $7,717,397 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-185945
The offering may be in the range of $14 million to $30 million. However, the projected offering amount is indefinite at this stage.
Source: Form D, filed Oct 23, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Peter C. Georgiopoulos | Director, Executive |
| Jonathan Singer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
299 Park Avenue, 2nd Floor
New York, NY, 10171
New York, NY, 10171